Lilly's Zepbound (tirzepatide) achieved total mean weight loss of 26.0% from baseline to 88 weeksDetailed results from SURMOUNT-4 have shown Zepbound (tirzepatide) injection achieved superior mean percent change in body weight...
Zepbound (tirzepatide) available in US pharmacies for adults living with obesityEli Lilly and Company has announced that Zepbound (tirzepatide) injection is now available in US pharmacies for adults with obesity (with...
FDA approves Lilly's Zepbound (tirzepatide) for chronic weight managementThe FDA has approved Eli Lilly and Company's Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment2 days ago